These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 11605090)

  • 1. Are African American patients at a higher risk for olanzapine-induced glucose intolerance?
    Ananth J; Gunatilake S; Aquino S; Bach V; Costa J
    Psychopharmacology (Berl); 2001 Sep; 157(3):324-5. PubMed ID: 11605090
    [No Abstract]   [Full Text] [Related]  

  • 2. Comparative study of the development of diabetes mellitus in patients taking risperidone and olanzapine.
    Fuller MA; Shermock KM; Secic M; Grogg AL
    Pharmacotherapy; 2003 Aug; 23(8):1037-43. PubMed ID: 12921249
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Olanzapine-induced diabetes mellitus.
    Bonanno DG; Davydov L; Botts SR
    Ann Pharmacother; 2001 May; 35(5):563-5. PubMed ID: 11346063
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Low blood glucose and olanzapine.
    Budman CL; Gayer AI
    Am J Psychiatry; 2001 Mar; 158(3):500-1. PubMed ID: 11230004
    [No Abstract]   [Full Text] [Related]  

  • 5. [Importance of blood glucose level when starting antipsychotic treatment].
    Dervaux A; Mascarenhas N; Lambolez T
    Presse Med; 2001 Sep; 30(26):1298. PubMed ID: 11603092
    [No Abstract]   [Full Text] [Related]  

  • 6. Hyperglycemia from olanzapine treatment in adolescents.
    Bloch Y; Vardi O; Mendlovic S; Levkovitz Y; Gothelf D; Ratzoni G
    J Child Adolesc Psychopharmacol; 2003; 13(1):97-102. PubMed ID: 12804130
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Olanzapine-induced glucose dysregulation.
    Bettinger TL; Mendelson SC; Dorson PG; Crismon ML
    Ann Pharmacother; 2000; 34(7-8):865-7. PubMed ID: 10928397
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Six-month review of weight and metabolic parameters in patients receiving clozapine, risperidone, olanzapine, or quetiapine.
    Kelly DL; Kreyenbuhl J; Love RC; Van-Duong Q; Conley RR
    J Clin Psychiatry; 2003 Sep; 64(9):1133-4. PubMed ID: 14628994
    [No Abstract]   [Full Text] [Related]  

  • 9. Adverse effects of high-dose olanzapine in treatment-refractory schizophrenia.
    Bronson BD; Lindenmayer JP
    J Clin Psychopharmacol; 2000 Jun; 20(3):382-4. PubMed ID: 10831029
    [No Abstract]   [Full Text] [Related]  

  • 10. Olanzapine-induced destabilization of diabetes in the absence of weight gain.
    Ramankutty G
    Acta Psychiatr Scand; 2002 Mar; 105(3):235-6; discussion 236-7. PubMed ID: 11939979
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Olanzapine and obsessive-compulsive symptoms.
    Lykouras L; Zervas IM; Gournellis R; Malliori M; Rabavilas A
    Eur Neuropsychopharmacol; 2000 Sep; 10(5):385-7. PubMed ID: 10974610
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Schizophrenia and schizoaffective disorder treated with high doses of olanzapine.
    Fanous A; Lindenmayer JP
    J Clin Psychopharmacol; 1999 Jun; 19(3):275-6. PubMed ID: 10350037
    [No Abstract]   [Full Text] [Related]  

  • 13. Hyperglycemia in patients with schizophrenia who are treated with olanzapine.
    Lindenmayer JP; Smith RC; Singh A; Parker B; Chou E; Kotsaftis A
    J Clin Psychopharmacol; 2001 Jun; 21(3):351-3. PubMed ID: 11386505
    [No Abstract]   [Full Text] [Related]  

  • 14. Interaction of olanzapine with fluvoxamine.
    de Jong J; Hoogenboom B; van Troostwijk LD; de Haan L
    Psychopharmacology (Berl); 2001 May; 155(2):219-20. PubMed ID: 11401013
    [No Abstract]   [Full Text] [Related]  

  • 15. Olanzapine-associated type 2 diabetes mellitus.
    Opp D; Hildebrandt C
    Schizophr Res; 2002 Jul; 56(1-2):195-6. PubMed ID: 12084434
    [No Abstract]   [Full Text] [Related]  

  • 16. Hyperglycemia associated with olanzapine.
    Fertig MK; Brooks VG; Shelton PS; English CW
    J Clin Psychiatry; 1998 Dec; 59(12):687-9. PubMed ID: 9921705
    [No Abstract]   [Full Text] [Related]  

  • 17. Hyperinsulinemia in psychiatric patients treated with olanzapine.
    Cohn TA; Remington G; Kameh H
    J Clin Psychiatry; 2002 Jan; 63(1):75-6. PubMed ID: 11838632
    [No Abstract]   [Full Text] [Related]  

  • 18. Near fatal ketoacidosis with olanzapine treatment.
    Straker D; Mendelowitz A; Karlin L
    Psychosomatics; 2002; 43(4):339-40. PubMed ID: 12189265
    [No Abstract]   [Full Text] [Related]  

  • 19. Hyperglycemia and olanzapine.
    Ober SK; Hudak R; Rusterholtz A
    Am J Psychiatry; 1999 Jun; 156(6):970. PubMed ID: 10360147
    [No Abstract]   [Full Text] [Related]  

  • 20. Atypical antipsychotics and cardiovascular risk in schizophrenic patients.
    Bouchard RH; Demers MF; Simoneau I; Alméras N; Villeneuve J; Mottard JP; Cadrin C; Lemieux I; Després JP
    J Clin Psychopharmacol; 2001 Feb; 21(1):110-1. PubMed ID: 11199934
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.